全文获取类型
收费全文 | 1433篇 |
免费 | 121篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 23篇 |
妇产科学 | 33篇 |
基础医学 | 123篇 |
口腔科学 | 70篇 |
临床医学 | 99篇 |
内科学 | 450篇 |
皮肤病学 | 32篇 |
神经病学 | 158篇 |
特种医学 | 10篇 |
外科学 | 169篇 |
综合类 | 18篇 |
一般理论 | 1篇 |
预防医学 | 126篇 |
眼科学 | 26篇 |
药学 | 171篇 |
中国医学 | 8篇 |
肿瘤学 | 33篇 |
出版年
2023年 | 9篇 |
2022年 | 14篇 |
2021年 | 27篇 |
2020年 | 16篇 |
2019年 | 21篇 |
2018年 | 22篇 |
2017年 | 26篇 |
2016年 | 27篇 |
2015年 | 30篇 |
2014年 | 47篇 |
2013年 | 47篇 |
2012年 | 82篇 |
2011年 | 76篇 |
2010年 | 45篇 |
2009年 | 44篇 |
2008年 | 43篇 |
2007年 | 64篇 |
2006年 | 50篇 |
2005年 | 66篇 |
2004年 | 61篇 |
2003年 | 57篇 |
2002年 | 48篇 |
2001年 | 37篇 |
2000年 | 50篇 |
1999年 | 34篇 |
1998年 | 9篇 |
1997年 | 12篇 |
1996年 | 14篇 |
1995年 | 7篇 |
1993年 | 9篇 |
1992年 | 34篇 |
1991年 | 28篇 |
1990年 | 22篇 |
1989年 | 42篇 |
1988年 | 25篇 |
1987年 | 27篇 |
1986年 | 41篇 |
1985年 | 36篇 |
1984年 | 31篇 |
1983年 | 38篇 |
1982年 | 19篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 13篇 |
1978年 | 7篇 |
1977年 | 11篇 |
1974年 | 11篇 |
1973年 | 12篇 |
1972年 | 7篇 |
1970年 | 7篇 |
排序方式: 共有1557条查询结果,搜索用时 0 毫秒
91.
Idiopathic Localised Bladder Amyloidosis is arare cause of haematuria and urinary tractsymptoms. A review of the literature highlightsthe varied presentations and the appropriateinvestigations for this condition, withemphasise on the exclusion of a secondarycause. In addition, the range of treatmentoptions is fully discussed. Our report on a 65-yearold gentleman illustrates that a highindex of suspicion is required for itsdiagnosis. Furthermore, conservative managementcan be an effective strategy in selectedpatients. 相似文献
92.
Spina MG Merlo-Pich E Akwa Y Balducci C Basso AM Zorrilla EP Britton KT Rivier J Vale WW Koob GF 《Psychopharmacology》2002,160(2):113-121
RATIONALE: Corticotropin-releasing factor (CRF) and urocortin (Ucn) belong to the CRF-related family, share a high degree of structural homology and bind to CRF receptors. However, compared with CRF, Ucn was shown to display either weaker or similar anxiogenic-like effects in vivo. OBJECTIVE: To compare the anxiogenic-like responses of rats injected intracerebroventricularly (ICV) with different doses of either rat/human CRF (r/hCRF) or rat Ucn (rUcn) at different intervals after injection. METHODS: Rats were tested on three validated paradigms of emotional behavior [i.e. elevated plus-maze (EPM), defensive withdrawal (DW) and conflict test (CT)] 5 and 30 min after treatment. RESULTS: In the EPM test only r/hCRF, but not rUcn, produced anxiogenic-like effects at the dose of 1.0 microg, when the peptides were injected 5 min before testing. At 30 min after injection, both peptides caused a significant reduction of open arms exploration, rUcn being effective at 0.01 microg. In the DW test both peptides were equally potent in decreasing the exploratory behavior and increasing the time spent in the chamber at the dose of 1.0 microg when tested 30 min after injection. In the CT both rUcn (0.25-1.0 microg) and r/hCRF (0.75-1.0 microg) decreased significantly the responding in the punished component. However, rUcn reduced food responding also in the unpunished component possibly due to its powerful anorectic activity. CONCLUSIONS: Comparison of anxiogenic-like activities of r/hCRF and rUcn at doses up to 1.0 microg revealed striking differential effects that depended on the time of testing after ICV peptide injection, and on the paradigm of anxiety used. These results suggest that the onset of r/hCRF and rUcn actions related to behavioral responses to anxiety is likely to depend on brain peptide-specific mechanisms including binding properties to CRF-receptors, differential distribution to specific functional brain sites and the distribution and effectiveness of binding-protein interactions. 相似文献
93.
Rivier J Gulyas J Kirby D Low W Perrin MH Kunitake K DiGruccio M Vaughan J Reubi JC Waser B Koerber SC Martinez V Wang L Taché Y Vale W 《Journal of medicinal chemistry》2002,45(21):4737-4747
We present evidence that members of the corticotropin releasing factor (CRF) family assume distinct structures when interacting with the CRF(1) and CRF(2) receptors. Predictive methods, physicochemical measurements, and structure-activity relationship studies have suggested that CRF, its family members, and competitive antagonists such as astressin [cyclo(30-33)[DPhe(12),Nle(21),Glu(30),Lys(33),Nle(38)]hCRF((12-41))] assume an alpha-helical conformation when interacting with their receptors. We had shown that alpha-helical CRF((9-41)) and sauvagine showed some selectivity for CRF receptors other than that responsible for ACTH secretion(1) and later for CRF2.(2) More recently, we suggested the possibility of a helix-turn-helix motif around a turn encompassing residues 30-33(3) that would confer high affinity for both CRF(1) and CRF(2)(2,4) in agonists and antagonists of all members of the CRF family.(3) On the other hand, the substitutions that conferred ca. 100-fold CRF(2) selectivity to the antagonist antisauvagine-30 [[DPhe(11),His(12)]sauvagine((11-40))] did not confer such property to the corresponding N-terminally extended agonists. We find here that a Glu(32)-Lys(35) side chain to side chain covalent lactam constraint in hCRF and the corresponding Glu(31)-Lys(34) side chain to side chain covalent lactam constraint in sauvagine yield potent ligands that are selective for CRF(2). Additionally, we introduced deletions and substitutions known to increase duration of action to yield antagonists such as cyclo(31-34)[DPhe(11),His(12),C(alpha)MeLeu(13,39),Nle(17),Glu(31),Lys(34)]Ac-sauvagine((8-40)) (astressin(2)-B) with CRF(2) selectivities greater than 100-fold. CRF receptor autoradiography was performed in rat tissue known to express CRF(2) and CRF(1) in order to confirm that astressin(2)-B could indeed bind to established CRF(2) but not CRF(1) receptor-expressing tissues. Extended duration of action of astressin(2)-B vs that of antisauvagine-30 is demonstrated in the CRF(2)-mediated animal model whereby the inhibition of gastric emptying of a solid meal in mice by urocortin administered intraperitoneally at time zero is antagonized by the administration of astressin(2)-B but not by antisauvagine-30 at times -3 and -6 h while both peptides are effective when given 10 min before urocortin. 相似文献
94.
95.
Vale J 《Current medical research and opinion》2000,16(Z1):s63-s67
There is little evidence to support a link between benign prostatic hyperplasia (BPH) and erectile dysfunction (ED). Any apparent relationship may reflect the fact that both are common conditions with a similar gender and age distribution. However, the surgical treatment of BPH (e.g. TURP or open prostatectomy) may cause ED as a postoperative complication in some patients. Similarly, the medical treatment of BPH with finasteride may be associated with ED (< 5% in one study). However, alpha-blockade is not associated with this side-effect. 相似文献
96.
Belcaro G Cesarone MR Nicolaides AN Vale J Glass J Lennox A 《Current medical research and opinion》2000,16(Z1):s72-s75
Local microcirculatory disturbances and fibrosis are thought to contribute to the pathogenesis of erectile dysfunction (ED). The assessment of these disturbances is now possible using non-invasive techniques such as laser Doppler flowmetry (LDF) and measuring transcutaneous pO2 and pCO2. However, these techniques need standardisation (e.g. in terms of equipment, conditions in which the examination is carried out and duration of measurement). Nevertheless, these techniques have a qualitative value. Marked alterations are seen in smokers and hypertensive patients. LDF has also been used to monitor the effect of treatment (e.g. after intracavernosal PGE1). These techniques remain non-diagnostic in individual patients. However, in groups of patients they may produce useful information (e.g. to assess treatments for ED). 相似文献
97.
W D Kornreich R Galyean J F Hernandez A G Craig C J Donaldson G Yamamoto C Rivier W Vale J Rivier 《Journal of medicinal chemistry》1992,35(10):1870-1876
Previous structure-activity relationship studies of CRF have shown that residues 1-4 were not necessary for receptor binding or transduction, that residues 4-8 were important for activation, and that residues 12-41 were mostly responsible for binding. Finally it was proposed that CRF assumed an alpha-helical structure when interacting with its receptor. By systematic substitution of each residue (except residues 1-4) in ovine CRF (oCRF) by Ala, we have investigated the role played by individual side chains in receptor recognition and activation. Out of 33 analogues (synthesized using SPPS on an MBHA resin, purified by RPHPLC and characterized by amino acid and mass spectral analyses), a significant loss of biological potency (less than 1% potency of native) was observed for 6 analogues ([Ala6], [Ala8], [Ala10], [Ala12], [Ala14], and [Ala38]); 12 analogues had biological potencies ranging from 1% to 60% and ranked as follows: [Ala35] less than [Ala16] less than [Ala9] less than [Ala19] less than [Ala15] less than [Ala13] less than [Ala7] less than [Ala23] less than [Ala11] less than or equal to [Ala21] less than [Ala27] less than or equal to [Ala18]; 8 analogues were found to be equipotent (greater than 60% and less than 150%) ([Ala5], [Ala17], [Ala26], [Ala29], [Ala30], [Ala34], [Ala36], and [Ala37]; and 7 analogues were found to be approximately 2-5 times more potent than native oCRF ([Ala25] = [Ala40] less than or equal to [Ala39] less than or equal to [Ala33] less than [Ala20] less than [Ala22] less than [Ala32], in an in vitro pituitary cell culture assay. In summary, the Ala substitutions which showed the greatest loss of potency (less than 1% of native oCRF) were those replacing hydrophobic residues while those showing the greatest increase in potency were replacing hydrophilic residues. Of the 22 Ala-containing analogues in the C-terminal half of the molecule, 17 analogues have equal or greater potencies than native oCRF. Substitution of Ala in the N-terminal region (residues 5-19) on the other hand is generally detrimental to biological activity. These results suggest that the side chains of residues 5-19 are very important for receptor binding and activation while, in the C-terminal region, the amino acid side chains may be more responsible for structural conservation than for functional expression. 相似文献
98.
99.
Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study 总被引:12,自引:0,他引:12
E B De Souza T R Insel M H Perrin J Rivier W W Vale M J Kuhar 《The Journal of neuroscience》1985,5(12):3189-3203
Corticotropin-releasing factor (CRF) receptor-binding sites have been localized and quantified in the rat central nervous system (CNS) by autoradiography with an iodine-125-labeled analogue of ovine CRF substituted with norleucine and tyrosine at amino acid residues 21 and 32, respectively. High affinity and pharmacologically specific receptor-binding sites for CRF were found in discrete areas within the rat CNS. CRF receptors were highly concentrated in laminae 1 and 4 throughout the neocortex, the external plexiform layer of the olfactory bulb, the external layer of the median eminence, several cranial nerve nuclei in the brainstem including the facial, oculomotor, trochlear, vestibulocochlear, and trigeminal nuclei, the deep cerebellar nuclei, and the cerebellar cortex. Moderate concentrations of CRF receptors were present in the olfactory tubercle, caudate-putamen, claustrum, nucleus accumbens, nucleus of the diagonal band, basolateral nucleus of the amygdala, paraventricular nucleus of the hypothalamus, mammillary peduncle, inferior and superior olives, medullary reticular formation, inferior colliculus, and brainstem nuclei including tegmental, parabrachial, hypoglossal, pontine, cuneate, and gracilis nuclei, and in spinal cord. Lower densities of CRF binding were found in the bed nucleus of the stria terminalis, central and medial amygdaloid nuclei, and regions of the thalamus, hypothalamus, hippocampus, and brainstem. The distribution of CRF-binding sites generally correlates with the immunocytochemical distribution of CRF pathways and with the pharmacological sites of action of CRF. These data strongly support a physiological role for endogenous CRF in regulating and integrating functions in the CNS. 相似文献
100.